SCHEMBL5565841

SCHEMBL5565841

CC(N)(C(=O)O)c1ccccc1.CCF

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.54
CYP2C19 P33261 3/20 0.54
CYP2D6 P10635 2/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
HIF1A Q16665 2/20 0.46
PKM P14618 1/20 0.43
CYP3A4 P08684 1/20 0.41
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
MAPK1 P28482 1/20 0.41
KIF11 P52732 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222049 0.90 CYP1A2 (0.58) CYP1A2CYP2C19CYP2D6MAPTKMT2A
SCHEMBL59841 0.90 CYP1A2 (0.58) CYP1A2CYP2C19CYP2D6MAPTKMT2A
SCHEMBL220775 0.90 CYP1A2 (0.58) CYP1A2CYP2C19CYP2D6MAPTKMT2A
Methyl Alcohol SCHEMBL29003577 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP2D6MAPTKMT2A
Hydrochloric Acid SCHEMBL1455022 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP2D6MAPTKMT2A
Hydrochloric Acid SCHEMBL304449 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP2D6MAPTKMT2A
Hydrochloric Acid SCHEMBL6369027 0.88 CYP1A2 (0.56) CYP1A2CYP2C19CYP2D6MAPTKMT2A
SCHEMBL30577995 0.81 CYP1A2 (0.50) CYP1A2CYP2C19CYP2D6MAPTKMT2A
SCHEMBL7384716 0.78 CYP2C9 (0.57) CYP1A2CYP2C19CYP2D6MAPTKMT2A
SCHEMBL18209210 0.78 CYP1A2 (0.47) CYP1A2CYP2C19CYP2D6MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539250-A1 RADIOACTIVELY LABELLED AMINO ACID ANALOGUES, THEIR PREPARATION AND USE Mallinckrodt Inc. (US) 2005-06-15 EP claimed
WO-2004110500-A1 RADIOACTIVELY LABELLED AMINO ACID ANALOGUES, THEIR PREPARATION AND USE MALLINCKRODT INC. (US) 2004-12-23 WO claimed
US-20070081941-A1 F-18 Labeled Amino Acid Analogs MALLINCKRODT INC. (US) 2007-04-12 US disclosed
US-7189383-B2 Radioactively labelled amino acid analogues, their preparation and use MALLINCKRODT INC. 2007-03-13 US disclosed
US-20060127306-A1 Radioactively labelled amino acid analogues, their preparation and use VRIJE UNIVERSITEIT BRUSSEL (BE) 2006-06-15 US disclosed
EP-1539250-A1 RADIOACTIVELY LABELLED AMINO ACID ANALOGUES, THEIR PREPARATION AND USE Mallinckrodt Inc. (US) 2005-06-15 EP disclosed
WO-2004110500-A1 RADIOACTIVELY LABELLED AMINO ACID ANALOGUES, THEIR PREPARATION AND USE MALLINCKRODT INC. (US) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070081941-A1 F-18 Labeled Amino Acid Analogs BCAT1, BCAT2, SLC1A5 CYP1A2 575/4885CYP2C19 175/4885CYP2D6 214/4885
US-20060127306-A1 Radioactively labelled amino acid analogues, their preparation and use BCAT1, BCAT2, SLC1A5 CYP1A2 150/4885CYP2C19 189/4885CYP2D6 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.